MIDLANDS MEDICAL PARTNERSHIP — All Prescriptions & Medications — Page 16
Practice Code: M85063 | BIRMINGHAM, B24 0SY
Showing results 751-800 of 1,040
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Flupentixol hydrochloride | 33 | 1,493 | £112 | +0.7% vs avg |
| Pimecrolimus | 33 | 1,180 | £722 | +94.9% ▲ |
| Glycopyrronium bromide | 33 | 1,190 | £1.9K | +38.5% ▲ |
| 33 | 659 | £2.5K | +422.8% ▲ | |
| 33 | 2,530 | £418 | +47.5% ▲ | |
| Vitamin A | 32 | 1,064 | £105 | +183.7% ▲ |
| Hyetellose | 32 | 1,800 | £798 | +297.4% ▲ |
| Hepatitis B | 32 | 32 | £358 | +202.4% ▲ |
| 32 | 674 | £8.3K | +365.9% ▲ | |
| 32 | 1,350 | £2.9K | +126.2% ▲ | |
| Pseudoephedrine hydrochloride | 31 | 1,618 | £184 | +495.2% ▲ |
| Magnesium citrate | 31 | 549 | £417 | +328.8% ▲ |
| Powder energy (carbohydrate) fortifier (0913211) | 31 | 1,470 | £1.3K | +843.6% ▲ |
| Fusidic acid | 31 | 155 | £583 | +200.1% ▲ |
| Antazoline | 31 | 450 | £144 | +597.8% ▲ |
| Ketorolac trometamol | 31 | 195 | £142 | +234.1% ▲ |
| 31 | 87.4K | £2.7K | +397.5% ▲ | |
| 31 | 100 | £1.8K | +330.4% ▲ | |
| Ulipristal acetate (Emergency Contraceptive) | 30 | 30 | £401 | +594.5% ▲ |
| Other oral iron preparations | 30 | 1,204 | £362 | +204.0% ▲ |
| Diclofenac sodium | 30 | 2,182 | £297 | +182.1% ▲ |
| 30 | 573 | £609 | +241.3% ▲ | |
| 30 | 3,540 | £6.0K | +41.7% ▲ | |
| 30 | 2,700 | £8.3K | +186.1% ▲ | |
| Glycopyrronium bromide | 29 | 4,760 | £5.5K | +41.3% ▲ |
| Erdosteine | 29 | 1,000 | £238 | +202.2% ▲ |
| Guaifenesin | 29 | 6,050 | £172 | +906.9% ▲ |
| Dexamfetamine sulfate | 29 | 1,350 | £1.2K | -19.3% ▼ |
| Exenatide | 29 | 106 | £2.6K | +65.4% ▲ |
| Ciclosporin | 29 | 1,520 | £1.3K | +73.7% ▲ |
| Tablets/capsules micronutrient supplement (0913282) | 29 | 2,520 | £1.7K | +176.9% ▲ |
| 29 | 4,440 | £5.8K | +196.4% ▲ | |
| 29 | 975 | £288 | +124.6% ▲ | |
| Diphenhydramine hydrochloride | 28 | 742 | £169 | +115.5% ▲ |
| Ibandronic acid | 28 | 303 | £309 | -22.9% ▼ |
| 28 | 1,470 | £3.1K | +236.2% ▲ | |
| 28 | 340 | £874 | +138.1% ▲ | |
| 28 | 2,010 | £1.3K | +102.1% ▲ | |
| 28 | 2,434 | £207 | +1.9% vs avg | |
| 28 | 910 | £2.5K | +104.8% ▲ | |
| Nicotine bitartrate | 27 | 4,212 | £442 | +439.3% ▲ |
| Erythromycin stearate | 27 | 2,120 | £449 | +907.6% ▲ |
| Methenamine hippurate | 27 | 1,908 | £573 | -70.3% ▼ |
| Vardenafil | 27 | 232 | £423 | +93.4% ▲ |
| Other calcium supplement preparations | 27 | 2,010 | £898 | +260.1% ▲ |
| Ciprofloxacin | 27 | 470 | £301 | +192.9% ▲ |
| 27 | 153 | £306 | +5.4% ▲ | |
| 27 | 180 | £521 | +188.7% ▲ | |
| Olmesartan medoxomil/amlodipine | 26 | 952 | £548 | +97.1% ▲ |
| Omega-3-acid ethyl esters | 26 | 1,176 | £570 | +23.0% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.